{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361699994337763840.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1200/jco.2001.19.5.1539"}},{"identifier":{"@type":"URI","@value":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2001.19.5.1539"}}],"dc:title":[{"@value":"Postmastectomy Radiotherapy: Clinical Practice Guidelines of the American Society of Clinical Oncology*"}],"description":[{"type":"abstract","notation":[{"@value":"<jats:p> OBJECTIVE: To determine indications for the use of postmastectomy radiotherapy (PMRT) for patients with invasive breast cancer with involved axil-lary lymph nodes or locally advanced disease who receive systemic therapy. These guidelines are intended for use in the care of patients outside of clinical trials. </jats:p><jats:p> POTENTIAL INTERVENTION: The benefits and risks of PMRT in such patients, as well as subgroups of these patients, were considered. The details of the PMRT technique were also evaluated. </jats:p><jats:p> OUTCOMES: The outcomes considered included freedom from local-regional recurrence, survival (disease-free and overall), and long-term toxicity. </jats:p><jats:p> EVIDENCE: An expert multidisciplinary panel reviewed pertinent information from the published literature through July 2000; certain investigators were contacted for more recent and, in some cases, unpublished information. A computerized search was performed of MEDLINE data; directed searches based on the bibliographies of primary articles were also performed. </jats:p><jats:p> VALUES: Levels of evidence and guideline grades were assigned by the Panel using standard criteria. A “recommendation” was made when level I or II evidence was available and there was consensus as to its meaning. A “suggestion” was made based on level III, IV, or V evidence and there was consensus as to its meaning. Areas of clinical importance were pointed out where guidelines could not be formulated due to insufficient evidence or lack of consensus. </jats:p><jats:p> RECOMMENDATIONS: The recommendations, suggestions, and expert opinions of the Panel are described in this article. </jats:p><jats:p> VALIDATION: Seven outside reviewers, the American Society of Clinical Oncology (ASCO) Health Services Research Committee members, and the ASCO Board of Directors reviewed this document. </jats:p>"}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1381699994337763849","@type":"Researcher","foaf:name":[{"@value":"Abram Recht"}],"jpcoar:affiliationName":[{"@value":"From the American Society of Clinical Oncology, Alexandria, VA."}]},{"@id":"https://cir.nii.ac.jp/crid/1381699994337763845","@type":"Researcher","foaf:name":[{"@value":"Stephen B. Edge"}],"jpcoar:affiliationName":[{"@value":"From the American Society of Clinical Oncology, Alexandria, VA."}]},{"@id":"https://cir.nii.ac.jp/crid/1381699994337763841","@type":"Researcher","foaf:name":[{"@value":"Lawrence J. Solin"}],"jpcoar:affiliationName":[{"@value":"From the American Society of Clinical Oncology, Alexandria, VA."}]},{"@id":"https://cir.nii.ac.jp/crid/1381699994337763840","@type":"Researcher","foaf:name":[{"@value":"David S. Robinson"}],"jpcoar:affiliationName":[{"@value":"From the American Society of Clinical Oncology, Alexandria, VA."}]},{"@id":"https://cir.nii.ac.jp/crid/1381699994337763846","@type":"Researcher","foaf:name":[{"@value":"Alison Estabrook"}],"jpcoar:affiliationName":[{"@value":"From the American Society of Clinical Oncology, Alexandria, VA."}]},{"@id":"https://cir.nii.ac.jp/crid/1381699994337763714","@type":"Researcher","foaf:name":[{"@value":"Richard E. Fine"}],"jpcoar:affiliationName":[{"@value":"From the American Society of Clinical Oncology, Alexandria, VA."}]},{"@id":"https://cir.nii.ac.jp/crid/1381699994337763715","@type":"Researcher","foaf:name":[{"@value":"Gini F. Fleming"}],"jpcoar:affiliationName":[{"@value":"From the American Society of Clinical Oncology, Alexandria, VA."}]},{"@id":"https://cir.nii.ac.jp/crid/1381699994337763844","@type":"Researcher","foaf:name":[{"@value":"Silvia Formenti"}],"jpcoar:affiliationName":[{"@value":"From the American Society of Clinical Oncology, Alexandria, VA."}]},{"@id":"https://cir.nii.ac.jp/crid/1381699994337763713","@type":"Researcher","foaf:name":[{"@value":"Clifford Hudis"}],"jpcoar:affiliationName":[{"@value":"From the American Society of Clinical Oncology, Alexandria, VA."}]},{"@id":"https://cir.nii.ac.jp/crid/1381699994337763848","@type":"Researcher","foaf:name":[{"@value":"Jeffrey J. Kirshner"}],"jpcoar:affiliationName":[{"@value":"From the American Society of Clinical Oncology, Alexandria, VA."}]},{"@id":"https://cir.nii.ac.jp/crid/1381699994337763850","@type":"Researcher","foaf:name":[{"@value":"David A. Krause"}],"jpcoar:affiliationName":[{"@value":"From the American Society of Clinical Oncology, Alexandria, VA."}]},{"@id":"https://cir.nii.ac.jp/crid/1381699994337763851","@type":"Researcher","foaf:name":[{"@value":"Robert R. Kuske"}],"jpcoar:affiliationName":[{"@value":"From the American Society of Clinical Oncology, Alexandria, VA."}]},{"@id":"https://cir.nii.ac.jp/crid/1381699994337763842","@type":"Researcher","foaf:name":[{"@value":"Amy S. Langer"}],"jpcoar:affiliationName":[{"@value":"From the American Society of Clinical Oncology, Alexandria, VA."}]},{"@id":"https://cir.nii.ac.jp/crid/1381699994337763847","@type":"Researcher","foaf:name":[{"@value":"George W. Sledge"}],"jpcoar:affiliationName":[{"@value":"From the American Society of Clinical Oncology, Alexandria, VA."}]},{"@id":"https://cir.nii.ac.jp/crid/1381699994337763843","@type":"Researcher","foaf:name":[{"@value":"Timothy J. Whelan"}],"jpcoar:affiliationName":[{"@value":"From the American Society of Clinical Oncology, Alexandria, VA."}]},{"@id":"https://cir.nii.ac.jp/crid/1381699994337763712","@type":"Researcher","foaf:name":[{"@value":"David G. Pfister"}],"jpcoar:affiliationName":[{"@value":"From the American Society of Clinical Oncology, Alexandria, VA."}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"0732183X"},{"@type":"EISSN","@value":"15277755"}],"prism:publicationName":[{"@value":"Journal of Clinical Oncology"}],"dc:publisher":[{"@value":"American Society of Clinical Oncology (ASCO)"}],"prism:publicationDate":"2001-03-01","prism:volume":"19","prism:number":"5","prism:startingPage":"1539","prism:endingPage":"1569"},"reviewed":"false","url":[{"@id":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2001.19.5.1539"}],"createdAt":"2017-02-24","modifiedAt":"2022-05-25","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360021389824664064","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The development and characterization of an all-purpose bolus for radiotherapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285707303873792","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Operation with less adjuvant therapy for elderly breast cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360289848628289792","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Supraclavicular failure after breast-conserving therapy in patients with four or more positive axillary lymph nodes when prophylactic supraclavicular irradiation is omitted"}]},{"@id":"https://cir.nii.ac.jp/crid/1360853567851815040","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Epidemiology and practice patterns for male breast cancer compared with female breast cancer in Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1363386073371855360","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Radiation therapy after breast-conserving surgery"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679457249920","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Recurrence after Sentinel Lymph Node Biopsy With or Without Axillary Lymph Node Dissection in Patients with Breast Cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679823392768","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"A CASE OF LIKELY RADIATION-INDUCED SYNCHRONOUS ESOPHAGEAL AND SKIN CARCINOMA FOLLOWING POST-OPERATIVE RADIATION FOR BREAST CANCER"},{"@language":"ja","@value":"乳癌術後放射線治療により２次発癌が疑われた食道・皮膚同時重複癌の１例"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1200/jco.2001.19.5.1539"},{"@type":"CROSSREF","@value":"10.2325/jbcs.14.16_references_DOI_KMi4V1bZhe8e90sqwGfas9CeKK6"},{"@type":"CROSSREF","@value":"10.1088/1361-6560/acc7e0_references_DOI_KMi4V1bZhe8e90sqwGfas9CeKK6"},{"@type":"CROSSREF","@value":"10.1007/s11604-009-0325-4_references_DOI_KMi4V1bZhe8e90sqwGfas9CeKK6"},{"@type":"CROSSREF","@value":"10.1016/j.jss.2016.05.031_references_DOI_KMi4V1bZhe8e90sqwGfas9CeKK6"},{"@type":"CROSSREF","@value":"10.3919/jjsa.70.3458_references_DOI_KMi4V1bZhe8e90sqwGfas9CeKK6"},{"@type":"CROSSREF","@value":"10.1002/cam4.3267_references_DOI_KMi4V1bZhe8e90sqwGfas9CeKK6"},{"@type":"CROSSREF","@value":"10.1007/s11604-005-0021-y_references_DOI_KMi4V1bZhe8e90sqwGfas9CeKK6"}]}